These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37052835)

  • 1. PFOA, PFHxA and C6O4 differently modulate the expression of CXCL8 in normal thyroid cells and in thyroid cancer cell lines.
    Coperchini F; De Marco G; Croce L; Denegri M; Greco A; Magri F; Tonacchera M; Imbriani M; Rotondi M; Chiovato L
    Environ Sci Pollut Res Int; 2023 May; 30(23):63522-63534. PubMed ID: 37052835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do PFCAs drive the establishment of thyroid cancer microenvironment? Effects of C6O4, PFOA and PFHxA exposure in two models of human thyroid cells in primary culture.
    Coperchini F; Greco A; Croce L; Teliti M; Calì B; Chytiris S; Magri F; Rotondi M
    Environ Int; 2024 May; 187():108717. PubMed ID: 38728818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new generation PFAS C6O4 does not produce adverse effects on thyroid cells in vitro.
    Coperchini F; Croce L; Pignatti P; Ricci G; Gangemi D; Magri F; Imbriani M; Rotondi M; Chiovato L
    J Endocrinol Invest; 2021 Aug; 44(8):1625-1635. PubMed ID: 33315184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D Reduces Thyroid Cancer Cells Migration Independently From the Modulation of CCL2 and CXCL8 Chemokines Secretion.
    Coperchini F; Greco A; Croce L; Petrosino E; Grillini B; Magri F; Chiovato L; Rotondi M
    Front Endocrinol (Lausanne); 2022; 13():876397. PubMed ID: 35498406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canagliflozin reduces thyroid cancer cells migration in vitro by inhibiting CXCL8 and CCL2: An additional anti-tumor effect of the drug.
    Coperchini F; Greco A; Croce L; Pignatti P; Muzza M; Petrosino E; Teliti M; Magri F; Rotondi M
    Biomed Pharmacother; 2024 Jan; 170():115974. PubMed ID: 38056240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-cancer effects of phenformin in thyroid cancer cell lines and in normal thyrocytes.
    Coperchini F; Croce L; Denegri M; Awwad O; Ngnitejeu ST; Magri F; Chiovato L; Rotondi M
    Oncotarget; 2019 Nov; 10(60):6432-6443. PubMed ID: 31741708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors.
    Coperchini F; Croce L; Denegri M; Awwad O; Ngnitejeu ST; Muzza M; Capelli V; Latrofa F; Persani L; Chiovato L; Rotondi M
    Sci Rep; 2019 Mar; 9(1):4390. PubMed ID: 30867499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective anti-CXCR2 receptor blockade by AZD5069 inhibits CXCL8-mediated pro-tumorigenic activity in human thyroid cancer cells in vitro.
    Coperchini F; Greco A; Petrosino E; Croce L; Teliti M; Marchesi N; Pascale A; Calì B; Pignatti P; Magri F; Uddin M; Rotondi M
    J Endocrinol Invest; 2024 Jun; ():. PubMed ID: 38900374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration.
    Awwad O; Coperchini F; Pignatti P; Denegri M; Massara S; Croce L; Di Buduo CA; Abbonante V; Balduini A; Chiovato L; Rotondi M
    J Endocrinol Invest; 2018 Nov; 41(11):1275-1282. PubMed ID: 29546654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Evaluation of the Effects of Legacy and New Generation Perfluoralkyl Substances (PFAS) on Thyroid Cells
    De Toni L; Di Nisio A; Rocca MS; Pedrucci F; Garolla A; Dall'Acqua S; Guidolin D; Ferlin A; Foresta C
    Front Endocrinol (Lausanne); 2022; 13():915096. PubMed ID: 35813651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal human thyroid cells, BCPAP, and TPC-1 thyroid tumor cell lines display different profile in both basal and TNF-α-induced CXCL8 secretion.
    Coperchini F; Pignatti P; Leporati P; Carbone A; Croce L; Magri F; Chiovato L; Rotondi M
    Endocrine; 2016 Oct; 54(1):123-128. PubMed ID: 26450713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Interferon-γ on the Basal and the TNFα-Stimulated Secretion of CXCL8 in Thyroid Cancer Cell Lines Bearing Either the RET/PTC Rearrangement Or the BRAF V600e Mutation.
    Rotondi M; Coperchini F; Awwad O; Pignatti P; Di Buduo CA; Abbonante V; Magri F; Balduini A; Chiovato L
    Mediators Inflamm; 2016; 2016():8512417. PubMed ID: 27555670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluoroalkylated substances (PFAS) affect neither estrogen and androgen receptor activity nor steroidogenesis in human cells in vitro.
    Behr AC; Lichtenstein D; Braeuning A; Lampen A; Buhrke T
    Toxicol Lett; 2018 Jul; 291():51-60. PubMed ID: 29601859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin reverts the secretion of CXCL8 induced by TNF-α in primary cultures of human thyroid cells: an additional indirect anti-tumor effect of the drug.
    Rotondi M; Coperchini F; Pignatti P; Magri F; Chiovato L
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E427-32. PubMed ID: 25590211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new PFAS C6O4 and its effects on marine invertebrates: First evidence of transcriptional and microbiota changes in the Manila clam Ruditapes philippinarum.
    Bernardini I; Matozzo V; Valsecchi S; Peruzza L; Rovere GD; Polesello S; Iori S; Marin MG; Fabrello J; Ciscato M; Masiero L; Bonato M; Santovito G; Boffo L; Bargelloni L; Milan M; Patarnello T
    Environ Int; 2021 Jul; 152():106484. PubMed ID: 33740673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle alterations due to perfluoroalkyl substances PFOS, PFOA, PFBS, PFBA and the new PFAS C6O4 on bottlenose dolphin (Tursiops truncatus) skin cell.
    Otero-Sabio C; Giacomello M; Centelleghe C; Caicci F; Bonato M; Venerando A; Graïc JM; Mazzariol S; Finos L; Corain L; Peruffo A
    Ecotoxicol Environ Saf; 2022 Oct; 244():113980. PubMed ID: 36057203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varied thyroid disrupting effects of perfluorooctanoic acid (PFOA) and its novel alternatives hexafluoropropylene-oxide-dimer-acid (GenX) and ammonium 4,8-dioxa-3H-perfluorononanoate (ADONA) in vitro.
    Zhang S; Chen K; Li W; Chai Y; Zhu J; Chu B; Li N; Yan J; Zhang S; Yang Y
    Environ Int; 2021 Nov; 156():106745. PubMed ID: 34246126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAFV600E and RET/PTC Promote Proliferation and Migration of Papillary Thyroid Carcinoma Cells In Vitro by Regulating Nuclear Factor-κB.
    Zhou D; Li Z; Bai X
    Med Sci Monit; 2017 Nov; 23():5321-5329. PubMed ID: 29117154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
    Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
    Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer.
    Nucera C; Nehs MA; Nagarkatti SS; Sadow PM; Mekel M; Fischer AH; Lin PS; Bollag GE; Lawler J; Hodin RA; Parangi S
    Oncologist; 2011; 16(3):296-309. PubMed ID: 21355020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.